IBR Inc. Philosophy

IBR Inc. is a premier contract research organization (CRO) focused on integral services in biopharmaceutical drug development. Continuous engagement in advanced technologies and sophisticated method development is the basis of our innovation and expertise.

Mission statement

We strive to meet our customer’s needs by providing high quality services at competitive prices. Continuous optimization of our structures and services is our commitment to maintain long term customer relationships, a prerequisite for growth and profit to our owners and employees.

Company policy

IBR Inc. is a CRO offering broad services in the field of preclinical and clinical development with a large number of established methods. The company has a core expertise in inflammatory research, cellular immunology, toxicology and pharmacokinetics. IBR Inc. is active in supporting drug development in these fields of expertise bringing innovation to the projects of our customers. By matching core expertise with customer requirements and well planned operation to meet agreed timelines, IBR Inc.strives to provide customer satisfaction whilst also achieving appropriate regulatory compliance.The company provides “high tech” platforms and is a centre of excellence in the above fields of core expertise. Active networking, joint-ventures and collaborations worldwide are part of our strategy.

IBR Inc. uses resources carefully and with regard to the protection of the environment. All principles and procedures are developed according to this philosophy. Whenever methods and procedures can be improved in this regard IBR Inc. management will push rapid implementation. Strict procedures for chemical and biological waste disposal are subject to continuous monitoring. There is a commitment to save energy whenever and wherever possible. Intelligent planning of lab work and procedures help to minimise the use of disposable material and diminish waste. IBR Inc. is committed to search for new possibilities of in-vitro test systems and strives to replace animal experiments whenever possible.

Biological, chemical and physical risks are evaluated during the validation procedures for equipment and methods, to form part of the safety arrangements of IBR Inc. laboratories, personnel and the environment. Individual project feasibility risks are subject to discussion within the team and, when necessary, with the customer. Actions taken to minimise the risks are included in the planning of each project.

Quality Standard

Good Laboratory Practice (GLP)

The laboratories are operated according to the internationally recognized OECD Principles of GLP and are within the inspection programme of the Swiss GLP Monitoring Authority, Swissmedic. The CEO is the GLP Test Facility Manager. Staff are trained in the requirements of GLP and monitoring is performed by independent Quality Assurance personnel.

Projects outside the scope of GLP

Projects that do not require GLP compliance are, wherever possible, performed to the same standard but unless specifically requested, these projects are not audited by Quality Assurance and the Report does not include a Statement of GLP compliance. Equipment also used for GLP studies is always used to the GLP standard as defined in IBR Inc. Standard Operating Procedures (SOPs). Reagents, equipment and laboratories are, where applicable, clearly labelled “Non-GLP”.

Submit a Question or Request

Simply fill out the form below and a member of our team will follow up with you shortly.


I accord my agreement for the usage and processing of my personal data for the purpose of processing my inquiry (see Privacy Policy). I am aware that I have the right to object the processing of my data at any time and with effect for the future.